KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Humana (HUM) Cost of Revenue (2016 - 2025)

Humana (HUM) has disclosed Cost of Revenue for 16 consecutive years, with $28.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Cost of Revenue changed N/A to $28.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $99.0 billion, a N/A change, with the full-year FY2025 number at $110.8 billion, up 10.08% from a year prior.
  • Cost of Revenue was $28.7 billion for Q4 2025 at Humana, up from $26.5 billion in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $28.7 billion in Q4 2025 to a low of $17.1 billion in Q2 2021.
  • A 4-year average of $20.4 billion and a median of $19.1 billion in 2022 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: rose 20.98% in 2021, then rose 6.17% in 2022.
  • Humana's Cost of Revenue stood at $17.4 billion in 2021, then rose by 6.56% to $18.6 billion in 2022, then rose by 17.02% to $21.7 billion in 2023, then surged by 32.08% to $28.7 billion in 2025.
  • Per Business Quant, the three most recent readings for HUM's Cost of Revenue are $28.7 billion (Q4 2025), $26.5 billion (Q1 2025), and $21.7 billion (Q3 2023).